animal model ͉ prostate cancer ͉ Pten conditional knockout ͉ stem cell proliferation and differentiation ͉ tumor progression P rostate cancer is the most common malignancy in men and the second leading cause of male cancer-related deaths in the Western world (1). The development of human prostate cancer proceeds through a series of defined states, initiating with prostatic intraepithelial neoplasia (PIN) and progressing to invasive hormone-dependent then -independent cancers (2, 3). The normal human prostatic epithelium consists of basal cells, transit amplifying͞intermediate cells (TA͞IC), secretory luminal cells, and neuroendocrine cells (4-6). Most human prostate cancers are adenocarcinomas and express markers associated with luminal epithelial cells. Because prostate cancer arises as a result of unbalanced cell proliferation, cell differentiation, and cell death, a central goal in prostate cancer biology is to identify the tumor precursor or tumor-initiating cells that are capable of maintaining tumor growth.
animal model ͉ prostate cancer ͉ Pten conditional knockout ͉ stem cell proliferation and differentiation ͉ tumor progression P rostate cancer is the most common malignancy in men and the second leading cause of male cancer-related deaths in the Western world (1) . The development of human prostate cancer proceeds through a series of defined states, initiating with prostatic intraepithelial neoplasia (PIN) and progressing to invasive hormone-dependent then -independent cancers (2, 3). The normal human prostatic epithelium consists of basal cells, transit amplifying͞intermediate cells (TA͞IC), secretory luminal cells, and neuroendocrine cells (4) (5) (6) . Most human prostate cancers are adenocarcinomas and express markers associated with luminal epithelial cells. Because prostate cancer arises as a result of unbalanced cell proliferation, cell differentiation, and cell death, a central goal in prostate cancer biology is to identify the tumor precursor or tumor-initiating cells that are capable of maintaining tumor growth.
The prostate is an androgen-dependent organ that undergoes involution after androgen withdrawal but can completely regenerate upon androgen restoration. Results from androgen ablation͞restoration cycling experiments on rodents suggest the existence of a population of long-lived, self-renewable stem cells (7, 8) that are responsible for maintaining the homeostasis of the prostate gland. These stem cells are proposed to be present predominantly in the basal cell layer of the human prostate gland (4, 9) . Using the kidney capsule reconstitution system initially developed by Cunha and Lung (10), Richardson et al. (11) demonstrated that human prostatic epithelial cells positive for CD133 have stem cell activity. Similarly, we found that the regenerative capacity of prostatic stem͞progenitor cells resides in a unique subpopulation of murine epithelial cells that express cell surface markers such as Sca-1 and that are sensitive for oncogenic transformation (12) . Consistent with BrdUrd labelretaining stem͞progenitor cells, the Sca-1 ϩ population is enriched in the proximal regions of the prostate gland (12, 13) .
Here, we report that altered stem͞progenitor cell proliferation is directly associated with prostate tumor initiation and progression in the Pten-null murine model. PTEN negatively regulates basal cell proliferation, and Pten deletion in the basal cells leads to expansion of Sca-1 ϩ and BCL-2 ϩ stem͞progenitor cells with concomitant differentiation. Collectively, our results illustrate that basal cell proliferation is an important event for prostate cancer initiation and early progression.
Results

Definition of Cell Types Associated with Murine Prostatic Epithelium
Compartment. To identify the cell of origin for prostate cancer, we first defined the cell types associated with the normal prostatic epithelium compartment. We chose the proximal region of the dorsolateral lobe to analyze because this region is enriched for the slow cycling, BrdUrd label-retaining, and Sca-1 ϩ stem͞ progenitor cells (8, 12, 13) .
To simultaneously colocalize the expression of multiple cellular markers, we performed dual or triple immunofluorescence analyses, using markers that have been used to identify subpopulations of human and murine prostatic epithelial cells (4, (14) (15) (16) . Our analysis showed that the normal mouse prostate epithelium consists of two distinct cell populations: the CK5 ϩ basal cells that are directly attached to the basement membrane (Fig. 1A, arrowheads) and the CK8 ϩ secretory cells that face the lumen ( Fig. 1 A, arrows) . In the WT prostate epithelium, all CK5 ϩ cells are positive for p63 (Fig. 1B) and occasionally positive for BCL-2 (indicated by the arrow in Fig. 1E ) but are negative for the cell proliferation marker Ki67 (Fig. 1C ) and the cell cycle inhibitor p27 kip1 (Fig. 1D ). The cadherin family is known to be a critical mediator of cell-cell adhesion and stem cell-niche interaction. Strong epithelial cadherin (E-cad) staining can be detected at the cell-cell junction between luminal cells and basal-luminal cells (Fig. 1F) . However, different from Drosophila germ stem cells in which E-cad serves as a glue to anchor germ stem cells to their niche (17, 18) , no E-cad staining can be detected at the interface of p63 ϩ basal cells and the basement membrane (Fig. 1F) 
Pten Deletion Leads to Increased Cell Proliferation Near the Basal Cell
Compartment. Cancer can originate from either a self-renewable stem cell population (20) or its differentiated progeny that have acquired self-renewal capacity owing to accumulated mutations (21) (22) (23) (24) . Unlike normal, replication-quiescent stem cells, tumorinitiating cells or their immediate progenitors are competent for continuous proliferation to maintain tumor growth (25) . When colocalizing Ki67, a cell proliferation marker, with the luminal and basal cell markers, we observed that most of the Ki67 ϩ cells are localized within or immediately above the basal cell compartment but are rarely associated with terminally differentiated luminal cells that are localized in the center of the hyperplastic duct (Fig. 3A) .
To directly evaluate the rate of cell proliferation, we gave a single dose of BrdUrd to 16-week-old mice and then quantified the percentage of BrdUrd-labeled cells 24 and 72 h later. The BrdUrd ϩ cells were further defined by luminal and basal cell markers. As shown in Fig. 3Bd and quantified in Fig. 3C , there is a 5-fold increase in BrdUrd pulse-labeled cells (green) in the Pten-null prostate gland as compared with the WT controls (Fig.  3Bb ). About 10% of these BrdUrd ϩ cells are p63 ϩ basal cells, in contrast to Ͻ0.01% in the WT controls (Fig. 3Bd , doublepositive cells are shown in yellow). Importantly, basal cells with ''symmetric-like'' cell divisions, in which two p63 ϩ nuclei are closely adjacent to each other (Fig. 3Bc , arrows) and with equal intensity of BrdUrd labeling (Fig. 3Bd, arrows) , are clearly evident in the mutant ducts but absent in the controls (Fig. 3B  a and b) . Three days after initial labeling, these BrdUrd ϩ cells began to form small clusters, which were closely associated with the basal cell compartment (Fig. 3Be) . On the basis of their cell proliferation potential, basal cells and cells immediately adjacent to the basal cell compartment, but not the luminal cell population, likely serve as tumor-initiating cells in the Pten-null prostate cancer model.
PTEN Loss Leads to Increased Stem͞Progenitor Cell Populations With-
out Blocking Differentiation. Recent work suggests that p63 is required to maintain the commitment of the urogenital sinus endoderm to the prostate cell lineage and that p63 ϩ basal progenitor cells are the precursors of luminal secretory cells (26) . To further study this hierarchical relationship and to test whether PTEN affects p63 ϩ basal cell differentiation, we performed dual immunohistochemical analysis using p63 to localize basal cell nuclei and CK5 to mark the cell boundary. Fig. 4A shows the events associated with initial cell differentiation in the Pten-null prostatic epithelium: the segregation of p63 ϩ basal cell and its In contrast to the WT prostatic epithelium shown in Fig. 1 , three distinct subpopulations could be easily identified within the multilayer epithelium of PIN lesions, depending upon the expression of basal and luminal cell markers: p63 and CK5 double-positive cells are predominantly restricted to the basal layer (Fig. 4B Left) , and CK8 ϩ terminally differentiated secretory cells face the luminal space (Fig. 4B, second panel from  left) . Clusters of CK5 and CK8 double-positive cells (Fig. 4B , second panel from left) are found between the basal and luminal cell layers, similar to the transient TA͞IC zone described in human prostate specimens (14) . Most of the cycling cells are localized in these TA͞IC clusters (Fig. 4B, third panel from left) .
Increased p27 (data not shown) and BCL-2 expression can also be detected in this region (Fig. 4B Right) Ϫ ). Pten deletion dramatically perturbs the basal and TA͞IC compartments, leading to increased basal cell density and expansion of the TA͞IC cell population. This phenotype is further extended from PIN to invasive adenocarcinoma lesions in which CK5 ϩ single-positive basal cell and CK5 ϩ ;CK8 ϩ double-positive TA͞IC cell numbers are consistently increased, and in many cases, mislocalized (Fig. 7 , which is published as supporting information on the PNAS web site).
Sca-1 Cell Surface Marker-Positive Cells Are Enriched in Pten-Null
Prostate Cancers. Recent work identified Sca-1 as a cell surface antigen that marks a subpopulation within the prostatic epithelial compartment with enhanced regenerative capacity and increased susceptibility to oncogenic transformation (12) . Sca-1 ϩ cells are enriched near the proximal region of the murine prostate ducts, and the Sca-1 cell surface antigen can be used for identifying prostate stem͞progenitor cells (12, 13). To determine whether Sca-1 ϩ cells are increased in the Pten-null prostate gland, we examined Sca-1 ϩ cells at different stages of tumor development. Starting at 4 weeks, at the hyperplastic stage (Fig. 5A) , a significant increase in the Sca-1 ϩ population was found in the Pten-null prostate glands. The Sca-1 ϩ population reaches its peak at 8 weeks, corresponding to the PIN lesion stage, with a 10-fold difference between mutants and WT controls (Fig. 5A Right) . Expression of a constitutively activated form of AKT͞PKB serine͞threonine kinase in WT epithelial cells gave a similar level of increase in the Sca-1 ϩ population and pathological progression in regenerated prostate cancer tissues (12) .
To further define the Sca-1 ϩ cell population, we separated the Sca-1 ϩ from the Sca-1 Ϫ cell population by FACS sorting. Quantitative PCR analysis demonstrated that some of the basal cell-associated genes, such as ⌬Np63 (27) and CK5 (Fig. 5B) , are highly expressed in the Sca-1 ϩ population. Western blot analysis further confirmed increased Sca-1 protein levels in the Pten-null prostate glands, starting at 8 weeks, accompanied by increased p63 protein levels (Fig. 8 , which is published as supporting information on the PNAS web site). Thus, the number of stem͞progenitor cells, identified either in situ by cell lineage markers or by expression of the Sca-1 cell surface antigen, increases progressively with time in Pten-null prostate glands.
Discussion
In this study, we used both cell lineage and cell surface markers to demonstrate the dynamic cellular changes associated with prostate cancer initiation and progression in the Pten-null murine model. Our study demonstrated that PTEN loss in prostatic basal cells has two major consequences: (i) it promotes basal cell division, leading to increased basal cell density, and (ii) it enhances cell differentiation, resulting in the production of more differentiated progeny corresponding to the TA͞IC cell population. Our results indicate that alterations in the basal and TA͞IC cell compartments are associated with prostate cancer initiation. These cells may serve as tumor-initiating cells in our Pten-null prostate cancer model. p63 is expressed in the regenerative epithelial compartment of several organs, including the prostate (27) (28) (29) . p63 knockout mice fail to develop multiple epithelial compartments such as the prostate (27) . Recent work suggests that p63 is required to maintain the commitment of the urogenital sinus endoderm to the prostate cell lineage and that the p63 ϩ basal progenitor cell is the cell of origin for luminal secretory cells (26) . Our study suggests that prostate cancer initiation in Pten-null mice is associated with increased p63 ϩ cell numbers and change in cell morphology and localization. In addition, PTEN loss leads to the expansion of the basal-derived TA͞IC cell population and a significant increase in the Sca-1 ϩ population whose gene expression profile overlaps with that of TA͞IC. The TA͞IC cell has been suggested to be the cell of origin for human prostate adenocarcinomas (4, 9, 14) . Consistent with this idea, previous studies demonstrated that PSCA, a marker associated with late TA͞IC prostate epithelial cells and highly expressed in human prostate cancers (30) , is up-regulated in Pten-null prostate cancers (31) , and the percentage of PSCA-positive cells is increased in the prostates of Pten-deleted animals (32). Of note, an increased Sca-1 ϩ population has been associated with mammary tumor stem cell activity (33) , although the functional significance of this increase remains to be tested.
The molecular mechanisms by which PTEN controls stem cell behavior are currently unknown. We have previously shown that PTEN loss leads to increased neural stem cell self-renewal and proliferation (34) , at least in part, by modulating the G 0 to G 1 cell cycle transition, a critical step for stem cell self-renewal and differentiation (35) . How PTEN controls prostatic stem cell selfrenewal and modulates the reciprocal interactions between niche and stem cells, stem cells and progenitors, and progenitors and terminally differentiated cell types needs to be investigated. Although an increase in the TA͞IC population is a common event in human and murine prostate cancer initiation, the role of TA͞IC cells as cancer stem cells is a subject of debate. Two scenarios have been proposed. In the first scenario, a slight change in stem cell number leads to a dramatic expansion of the TA population, which serves as a precursor for luminal epithelial cells and is capable of rapid cell division. Although the amplification of TA cells is a common event observed during prostate cancer development, the real tumor-initiating cells are their parents, the mutated stem cells. Alternatively, the second scenario suggests that oncogenic events may not take place in the stem cell population. Instead, TA cells with limited replicative capacity can be transformed by acquiring self-renewal potential (23) . Our current study cannot distinguish between these two possibilities. Future studies with lineage-specific labeled transgenic mice may provide additional information toward answering this fundamental question.
There are both significant similarities and differences in the gross and microscopic anatomy of the rodent and the human prostate. These need to be considered when comparing results derived from murine models with results derived from human prostate (36) . Unlike the single lobular structure of the human prostate gland, the mouse prostate gland has four paired lobes (36) . Besides this anatomic difference, our detailed analysis indicates several differences between human and murine prostatic epithelium: e.g., TA͞IC cells, marked by their concomitant expression of both CK5 and CK8 markers, are below our threshold of detection in the WT murine prostate gland (Fig.  1 A) . In addition, human basal cells are positive for p27 and BCL-2 (4), whereas murine basal cells do not express or only occasionally express p27 and BCL-2 ( Fig. 1 D and E , arrowheads). Our study also suggests that prostate cancer initiation in Pten-null mice is associated with an increased p63 ϩ cell number and a change in cell morphology and localization. These results seem to contradict reports on human prostate cancers, in which the presence of p63 ϩ cells is negatively correlated with progression of adenocarcinoma (37, 38) . This discrepancy may be due to the different anatomies of human and murine prostates (36) . Because our study concentrated on the proximal region of the dorsolateral prostate lobe, an area highly enriched for the stem͞progenitor cell population (12, 13), we may have had a unique opportunity to observe a significant association of stem͞ progenitor cells with tumor initiation and progression. Of note, we observed that murine tumors located distal from the urethra often lack p63 ϩ cells. Further study is needed to determine whether there are stem cell-rich areas in the human prostate gland that contribute to prostate cancer formation.
Materials and Methods
Histology and Immunochemistry Analysis. Tissue samples were prepared as described by Wang et al. (31) . To visualize f luorescence, signals were amplified by using a PerkinElmer Life Sciences (Boston) TSA-Plus Cy3͞Cy5͞FITC System. Slides were incubated for 1 h at room temperature or 4°C overnight with the following antibodies diluted according to manufacturers' instructions: anti-p63 (BD Pharmingen, catalog no. 559951), anti-CK-5 and anti-CK-8 (Covance Research Products, Denver, PA; catalog nos. AF 138 and HK-8), anti-Ki67 polyclonal antibody (Novocastra, Newcastle, U.K.; catalog no. NCL-Ki67p), anti-AR (Upstate Biotechnology, Lake Placid, NY; catalog no. 06-680), anti-BCL-2 (BD Biosciences, Franklin Lakes, NJ; catalog no. 610538), and antiBrdUrd (BD Biosciences, catalog no. 551321). Signals were amplified by using the biotin-streptavidin-based detection system from BioGenex Laboratories (San Ramon, CA). Brief ly, slides were first incubated with biotinylated antimouse IgG (or anti-rabbit IgG for rabbit polyclonal antibody) and then incubated with streptavidin-conjugated peroxidase (BioGenex Laboratories) for 30 min at room temperature. Tyramide signal amplification reagent (PerkinElmer Life Sciences, catalog no. NEL741) with the appropriate f luorescent dye was added to the slides for 5 min, and a cover slide was mounted with antifading f luorescent mounting media containing DAPI (Vector Laboratories, catalog no. H1200). Samples were visualized with an Olympus (Melville, NY) BX60 f luorescence microscope or a Leica (Bannockburn, IL) TCS-SP confocal microscope. BrdUrd Pulse Labeling. Two mice at each time point from each genotype group were injected with a single dose of BrdUrd (i.p., dissolved in PBS to a final concentration of 10 mg͞ml) at 100 mg͞kg body weight. Prostates were harvested along with small intestine, which served as a positive control, 24 or 72 h after injection.
Quantification of p63 ؉ , CK5 ؉ , Ki67 ؉ , and BrdUrd ؉ Cells. Prostate sections were stained with antibody against p63, CK5, BrdUrd, and Ki67 and visualized by using either the BioGenex Laboratories DAB system or PerkinElmer Life Sciences TSA reagent. After counterstaining and mounting, 300-400 epithelial cell nuclei in the proximal regions of the dorsolateral lobes were marked for each mouse prostate, and nuclei positive for p63, CK5, Ki67, and BrdUrd were counted. The number of p63-positive nuclei was reported either as a percentage (per 100 nuclei) or as a density (per micrometer of basement membrane). All quantification and measurements were done by using IMAGEPRO software (Media Cybernetics, Silver Spring, MD). Similar measurements were done for CK-5-, BrdUrd-, and Ki67-positive nuclei.
